Results 231 to 240 of about 150,574 (342)

Does a Restrictive Diagnostic Work‐up for Thyroid Nodules Lead to a Different Papillary Thyroid Cancer Patient Population? A Comparison Between Dutch and U.S. T1‐T3 Patient Population

World Journal of Surgery, Volume 49, Issue 4, Page 985-996, April 2025.
Does a restrictive diagnostic work‐up for thyroid nodules lead to a different papillary thyroid cancer patient population? A comparison between Dutch and U.S. PT1–T3 patient population. Abstract Introduction The 2015 American Thyroid Association guidelines recommend de‐escalating surgical treatment for papillary thyroid cancer (PTC).
Maaike B. C. ten Hoor, Jia F. Lin, Madelon J. H. Metman, Pedro M. Rodriguez Schaap, Thera P. Links, Renske Altena, Tessa M. van Ginhoven, Wouter T. Zandee, Anton F. Engelsman, Schelto Kruijff   +9 more
wiley   +1 more source

Comparative urine proteomic study involving papillary thyroid carcinoma and benign thyroid nodules. [PDF]

Front Oncol
Wei L, Xiao R, Guo Z, Wang P, Zhao K, Zhou Y, Sun W, Cao Y.   +7 more
europepmc   +1 more source

Many Faces of Mixed Medullary-Follicular and Papillary Carcinoma of the Thyroid

, 1998
Tsuyoshi Monden, Masatomo Mori
openalex   +2 more sources

Papillary thyroid carcinoma

Radiopaedia.org, 2020
F. Limaiem, A. Rehman, Thomas Mazzoni
semanticscholar   +1 more source

Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome

British Journal of Haematology, Volume 206, Issue 4, Page 1109-1120, April 2025.
Summary Germline variants in DDX41 (DDX41MT‐germline predisposition syndrome [GPS]) are associated with predisposition to haematological malignancies (HM), including lymphoid and myeloid neoplasms (MN). We retrospectively analysed the clinical and molecular features of 195 patients diagnosed and treated at Mayo Clinic with DDX41MT‐GPS.
Yael Kusne, Talha Badar, Terra Lasho, Ludovica Marando, Abhishek A. Mangaonkar, Christy Finke, James M. Foran, Aref Al‐Kali, Jeanne Palmer, Cecilia Arana Yi, Hassan B. Alkhateeb, Naseema Gangat, David Viswanatha, Mark R. Litzow, Timothy Chlon, Alejandro Ferrer, Mrinal M. Patnaik   +16 more
wiley   +1 more source

MAP17 contributes to the tumorigenesis of papillary thyroid carcinoma by activating the AKT signaling pathway. [PDF]

Arch Endocrinol Metab
Tian ZH, Huang R, Li GQ, Zhu YX.
europepmc   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review

British Journal of Pharmacology, Volume 182, Issue 7, Page 1416-1445, April 2025.
Abstract In the past year, the European Medicines Agency (EMA), the Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency (MHRA) authorised 53 novel drugs. While the 2024 harvest is not as rich as in 2023, when 70 new chemical entities were approved, the number of ‘orphan’ drug authorisations in 2024 (21) is ...
Stavros Topouzis, Andreas Papapetropoulos, Steve P. H. Alexander, Miriam Cortese‐Krott, Dave A. Kendall, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Mauro M. Teixeira, Nathalie Vergnolle, Xin Wang, Péter Ferdinandy   +16 more
wiley   +1 more source

An uncommon variant, Warthin‑like papillary thyroid carcinoma: A case report. [PDF]

Mol Clin Oncol
Altunsu S, Dagdemir B, Toper MH, Ari N, Ergenc M.   +4 more
europepmc   +1 more source

A Retrospective Study of T4 Papillary Thyroid Carcinoma.

, 1998
Keiichi Chijiwa, Kazunori Mori, Tadashi Nakashima   +2 more
openalex   +2 more sources

CYP24A1 Binding to FUS Maintains Tumor Properties by Regulating the miR‐200c/ZEB1/EMT Axis

Cancer Science, Volume 116, Issue 4, Page 910-922, April 2025.
The active vitamin D‐degrading enzyme (CYP24A1) is a potential oncogene in ovarian and lung cancer. Mechanically, 87–297 amino acid motif of CYP24A1 bound specifically to FUS protein, consequentially reducing FUS affinity for miR‐200c. A reduction in miR‐200c levels resulted in a significant activation of its target gene ZEB1, thereby facilitating the ...
Ping Wang, Jiming Xu, Weijing You, Jie Li, Jing Yu, Fei Jiang, Zengli Zhang, Wentao Hu, Bingyan Li   +8 more
wiley   +1 more source